Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

Language

Rare Invasive Fungal Infections (IFI) post allo- and auto-HCT

Retrospective Studies

Complications: infectious

Infectious Diseases Working Party (IDWP)

Type of treatment

Principal investigator

Simone Cesaro & Maria Pia Esposto, Aliénor Xhaard & Silvia Corcione, Malgorzata Mikulska & Claudia Bartalucci

Management of CNS infections in patients after haematopoietic stem cell transplantation and CAR T cell therapy – a survey on behalf of the EBMT IDWP

Closed Survey/Study

Complications: infectious

Infectious Diseases Working Party (IDWP)

Type of treatment

Principal investigator

Martin Schmidt-Hieber

Retrospective multicentre study on the rate, predictors and outcome of pre-engraftment and post-engraftment CR-GN BSI among CR-GN-colonised auto-HCT and allo-HCT recipients

Retrospective Studies

Complications: infectious

Infectious Diseases Working Party (IDWP)

Type of treatment

Principal investigator

Malgorzata Mikulska

Toxoplasmosis practices in allogeneic stem cell transplantation (allo-HCT) patients, a survey by the EBMT IDWP

Retrospective Studies

Complications: infectious

Infectious Diseases Working Party (IDWP)

Type of treatment

Principal investigator

Fabio Andreozzi

IDWP-CTIWP: Survey on vaccination strategy in CAR-T patients

Closed Survey/Study

Infectious Diseases Working Party (IDWP)

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type of treatment

Principal investigator

Agnieszka Piekarska

Outcome of adult patients with HIV undergoing autologous or allogeneic haematopoietic cell transplantation

Retrospective Studies

Infectious Diseases Working Party (IDWP)

Type of treatment

Principal investigator

Annalisa Paviglianiti

Résultats cliniques chez les patients adultes vivant avec le VIH après une greffe de cellules souches hématopoïétiques autologue ou allogénique

Études rétrospectives

Toutes les maladies

Infectious Diseases Working Party (IDWP)

Type of treatment

Principal investigator

Annalisa Paviglianiti

Maribavir use for CMV infection in allogeneic stem cell transplantation: the real-world experience. A retrospective study of IDWP EBMT

Retrospective Studies

Complications: infectious

Infectious Diseases Working Party (IDWP)

Type of treatment

Principal investigator

Annalisa Paviglianiti

Utilisation du maribavir pour l'infection à CMV après une allogreffe de cellules souches : l'expérience en vie réelle. Une étude rétrospective de l'IDWP-EBMT.

Études rétrospectives

Complications : infectieuses

Infectious Diseases Working Party (IDWP)

Type of treatment

Principal investigator

Annalisa Paviglianiti

Incidence and outcome of post-transplant haemorrhagic cystitis in patients who undergo allogeneic haematopoietic cell transplantation

Closed Survey/Study

Infectious Diseases Working Party (IDWP)

Type of treatment

Principal investigator

Survey on ICU organization and ICU admission after haematopoietic cell transplantation with special emphasis on infectious causes

Closed Survey/Study

Infectious Diseases Working Party (IDWP)

Complications Working Party (CWP)

Type of treatment

Principal investigator

Joanna Drozd-Sokolowska

Infections following CAR-T therapy. A retrospective collaborative study between the Infectious Diseases Working Party (IDWP), the Cellular Therapy and Immunobiology Working Party (CTIWP), the Transplant Complications Working Party (TCWP) of the EBMT, the European Hematology Association (EHA), and the Medical College of Wisconsin.

Closed Survey/Study

Non-Hodgkin’s Lymphoma (NHL)

Acute Lymphatic Leukaemia (ALL)

GoCART Coalition

Infectious Diseases Working Party (IDWP)

Cellular Therapy & Immunobiology Working Party (CTIWP)

Complications Working Party (CWP)

Type of treatment

Principal investigator